The United States Securities and Exchange Commission (SEC) has postponed its decisions on three applications for spot Bitcoin exchange-traded funds (ETFs).
According to SEC filings dated Aug. 31, the commission has designated a longer period in which it may review spot Bitcoin (BTC) ETF applications from WisdomTree, Invesco and Valkyrie. The SEC will have another 45 days upon publication in the Federal Register to consider the proposed rule changes allowing listing of the investment vehicles, giving the regulator until October to approve, deny or delay a decision.
The delays followed speculation that the SEC could approve a spot Bitcoin ETF in the U.S. for the first time after the commission lost a crucial court case brought by asset manager Grayscale. An appellate court ruled on Aug. 29 the SEC would need to review Grayscale’s petition to convert its Bitcoin Trust into an ETF, leading many experts to suggest the odds for approval of at least one spot crypto ETF had significantly increased.
Still no delay announcement for BlackRock, even tho their’s was due before Valkyrie’s and they using same exchange. Also no Fidelity or Bitwise delays. Watch them wait till tomorrow on those just to mess with everyone’s heads.. https://t.co/wbHSss16w5
— Eric Balchunas (@EricBalchunas) August 31, 2023
Related: Grayscale wins the court battle, but what does this mean for a spot Bitcoin ETF?
WisdomTree’s Bitcoin ETF proposal didn’t get the SEC’s approval following a 2021 filing. However, after BlackRock joined the spot Bitcoin ETF race, WisdomTree refiled its application. In July, following reports that the SEC would be more open to accepting ETF applications with a surveillance-sharing agreement, some firms refiled, naming crypto exchange Coinbase as a partner.
WisdomTree, Valkyrie and Invesco are three of many firms with crypto ETF applications in the SEC pipeline, including BlackRock, ARK Invest, Bitwise Asset Management, VanEck and Fidelity. The deadline for the SEC to reach a decision or delay Bitwise’s BTC investment vehicle is Sept. 1, suggesting the commission will likely make an announcement soon.
alphabetical list of allergy medications what is allergy medicine called claritin allergy sinus 12hr costco